PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine HCl 0.1% in 0.9% Sodium Chloride Injection-200 mL Tot...

FDA Drug Recall #D-0149-2020 — Class II — October 9, 2019

Recall Summary

Recall Number D-0149-2020
Classification Class II — Moderate risk
Date Initiated October 9, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
Location West Columbia, SC
Product Type Drugs
Quantity 615 bags

Product Description

PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine HCl 0.1% in 0.9% Sodium Chloride Injection-200 mL Total Dose: (400 mcg/200 mg)/200 mL, Rx Only Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-526-20

Reason for Recall

GMP Deviations: potential glass contamination

Distribution Pattern

Nationwide.

Lot / Code Information

Lot: FR9002A Exp. 12/12/2019

Other Recalls from Nephron Pharmaceuticals Corporation d...

Recall # Classification Product Date
D-0154-2020 Class III PF-Succinylcholine Chloride Injection, USP 20 m... Oct 21, 2019
D-0150-2020 Class II Amino Acid Injection 50 g/1000 mL (50 mg/mL) 25... Oct 9, 2019
D-0148-2020 Class II PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl... Oct 9, 2019
D-0147-2020 Class II PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine H... Oct 9, 2019
D-0151-2020 Class II del Nido Cardioplegia Solution, 1000 mL, Single... Oct 9, 2019

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.